May 5, 2015

Improving Management of the Controlled Substances Quota Process

The hearing explores the findings and recommendations of a recent Government Accountability Office report which highlights challenges with the Drug Enforcement Administration and the Food and Drug Administration’s management the Controlled Substances quota process.

Opening Statements

CHAIRMAN (R - IA)

Chuck Grassley

Sen. Grassley’s opening statement, as prepared for delivery.

CO-CHAIR (D - CA)

Dianne Feinstein

Sen. Feinstein’s opening statement, as prepared for delivery.

Witnesses

Marcia Crosse

Director of the Health Care Team at the U.S. Government Accountability Office (GAO), Washington, D.C.

Captain Valerie Jensen

Associate Director of the Drug Shortages Program at the Food and Drug Administration (FDA), Washington, D.C.

Joseph Rannazzisi

Deputy Assistant Administrator of Drug Diversion with the Drug Enforcement Administration (DEA), Washington, D.C.